New AAU Head Sees Stormy Future For University Science Departments

Academic science in the United States is in for some rough times from the government, according to the newly appointed president of the Association of American Universities (AAU). "This is a time of challenge, perhaps more than we've seen in several decades--when major research universities are acting under some duress and, perhaps, when some science in the U.S. has come somewhat into question," says Cornelius J. Pings, provost and senior vice president for academic affairs at the University o

Written byRon Kaufman
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

"This is a time of challenge, perhaps more than we've seen in several decades--when major research universities are acting under some duress and, perhaps, when some science in the U.S. has come somewhat into question," says Cornelius J. Pings, provost and senior vice president for academic affairs at the University of Southern California in Los Angeles. He will assume the AAU presidency on February 15.

Pings will succeed Robert M. Rosenzweig, who has served a decade in the post. Rosenzweig, the vice president for public affairs at Stanford University before joining AAU, will now do university consulting and writing from his home in California.

Pings, who has a Ph.D. in chemical engineering, identifies some members of the U.S. legislative and executive branches of government as being particularly wary about the money currently allocated to support scientific research.

"Appropriations being approved by Congress are flat, or of a lesser rate of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies